Category Archives: XBI

S&P … Almost ‘There’

October 3, 2026 By in $SPSIBI, AZO, Biotech, BKNG, DUOL, HD, KMX, LOW, S&P, S&P 500, Semiconductors, SPBIO, Speck-Effect, SPY, The Speck, XBI, XBI-26-17 Leave a comment

‘There’, is a new All-Time High

Two weeks ago, was this update showing the (net) upward progress of the S&P was slowing (not advice, not a recommendation).

Then, two days later was this, presenting how the index might make it to another high.

Now, the SPY chart is mimicking the longer timeframe by having successive shorter thrusts (magenta arrows).

At this point it’s a toss-up but does it really matter?

Meaning, if the downside is being worked (shorted), large numbers of tickers are already in essentially free-fall: AZO, BKNG, DUOL, HD, KMX, LOW; way below their all-time highs (not advice, not a recommendation).

Note: All have been covered at some point, on this site.

One sector that’s not cracked (yet) but seems to be building up immense pressure, is biotech.

Barring any unforeseen event, XBI is covered next.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Top … So, Far

September 29, 2026 By in $SPSIBI, Biotech, SPBIO, Up-Thrust, XBI, XBI-26-16 Leave a comment

Subdividing Lower

Looking at the chart from left-to-right, the peaks are lower and the lows, are lower.

As noted, today was an apparent up-thrust (reversal), with a test coming towards the close.

After-hours action (as of 7:40 p.m., EST) is holding steady; no movement up or down.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Axis of Biotech

September 28, 2026 By in Biotech, SPBIO, $SPSIBI, XBI, XBI-26-16 Leave a comment

Underside Test

The chart segment of XBI shows its posted an axis line over the past few months.

There have been oscillations on both sides, with today being an underside test.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech (may) Bounce

September 24, 2026 By in Biotech, The Speck, SPBIO, Speck-Effect, XBI Leave a comment

And Then?

Fibonacci ‘Day 21’, was a swift wide bar down move.

Wide bars tend to get tested, and we see that happening today and possibly tomorrow (not advice, not a recommendation).

When looking at the left side of the chart (compared to right), volatility has increased, indicating instability.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Market Highs, Weeks, Months Ago

September 18, 2026 By in $SPSIBI, Artificial Intelligence, Biotech, DIA, Dow 30, House of El - AI, Nasdaq, Ox Talks, QQQ, S&P, S&P 500, Semiconductors, SOXX, SPY, XBI, XBI-26-11, XBI-26-12

Dow, S&P, Qs Et al.

The Dow (DIA) all-time highs were on August 5th, the S&P (SPY) on August 13th, the Qs (QQQ), way back on June 3rd; Semiconductors (SOXX), June 22nd, and the list goes on.

We have updates by the day, if not the hour, like this, this, and this, letting us know in real-time, the air’s coming out of the bubble (not advice, not a recommendation).

So, ‘gentlemen, start your engines‘ 🙂

Pick your market

Biotech XBI, Daily

The chart has an added bonus, showing the potential trading channel.

Trade Action: Yesterday, XBI-26-11, was exited at break even, then re-established (short) as XBI-26-12, and well-in-the-green by the close (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech (channel) Breakdown

September 15, 2026 By in Biotech, IBB, SPBIO, $SPSIBI, XBI, IBB-26-05, XBI-26-11

Off The Cliff?

We won’t know for sure, until a long time from now … when it’s all over (not advice, not a recommendation).

Yesterday’s action in biotech IBB, posted a new daily high, while at the same time, XBI moved higher but was unable to post a new high.

Trade Action: IBB-26-05, was exited with profit and the short re-established as XBI-26-11 (not advice, not a recommendation).

As the chart shows (blue arrows), that XBI short was increased during today’s session.

Biotech XBI, Daily

We’re still at the far-right side, the ‘supply side’.

If the entire channel is in-effect, the ‘demand side’, is a long way away.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech follows Amgen … Down

September 8, 2026 By in $SPSIBI, AMGN, Biotech, IBB, IBB-26-05, SPBIO, XBI, XBI-26-10

IBB, Below Support

Amgen was whacked for a -10.08% loss during today’s session.

Biotech IBB, XBI, followed suit; down -2.17% and -1.15%, respectively.

Both indexes retraced during the day; it was noted XBI’s retrace was 50%, while IBB’s retrace as 38%.

Therefore, the trading response was to close short-trade XBI-26-10 (for profit), re-establish that short via IBB, as IBB-26-05 (not advice, not a recommendation).

Note in the chart above, the last time IBB pushed below support, it was in spring position and moved higher the next three sessions.

Markets tend to alternate.

Let’s see what happens next.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Tesla ‘Channel’

September 6, 2026 By in Transportation, TSLA, XBI, XBI-26-10

Right Way … Wrong Way

Potential false upside breakout moves from a down-channel, have happened before.

Once such occurrence, was here.

Let’s see if the trendline was drawn correctly, or not.

The segment is a closer view of where TSLA left-off last Friday.

If it’s in the channel, watch for a lower open and acceleration lower (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Moderna ‘Stretched’

September 5, 2026 By in Biotech, MRNA, SPBIO, XBI, XBI-26-10

The Most, Ever

The effect of Moderna’s single day +176.97% move, can be directly seen in biotech XBI gaining +5.90%, the same day.

Since then, it’s been just over two-weeks and already, Wall St. has ‘cooled‘ to Moderna.

You can’t make this up. 🙂

With that said, and from a market behavior standpoint alone, wide high-volume price bars, tend to be tested (not advice, not a recommendation).

Moderna MRNA, Weekly

With MRNA slamming into resistance, highest volume, widest bar, ever, sort of says ‘Ruh Roh‘.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech (short) Close-Up

September 4, 2026 By in Biotech, XBI, XBI-26-10

Documenting The Trade

Yesterday’s trade was a stretch to go short on biotech XBI, without (confirmation) posting a new daily low (yet),

Today, the new daily low … just barely.

What that does from a trading standpoint, is provide a definitive stop; yesterday’s high (not advice, not a recommendation).

From the chart, we’re at the edge of congestion with price action struggling to make new highs … that so far, are not happening.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279